Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

Stock Markets Sep 29, 2022 10:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
 
BIIB
-0.98%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Gold
-0.21%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IXIC
-0.18%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BIIB34
-1.85%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ENRY
-0.80%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
  • Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares rose 103.8% to close at $9.58 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
  • Prothena Corporation plc (NASDAQ: PRTA) shares jumped 87.5% to close at $58.00 on Wednesday after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative diseases, like Alzheimer’s.
  • SOBR Safe, Inc. (NASDAQ: SOBR) climbed 83% to close at $2.47 after the company announced its SOBRcheck is replacing breathalyzers in the American judicial system.
  • BTRS Holdings Inc. (NASDAQ: BTRS) gained 60.8% to close at $9.28. The EQT X fund agreed to acquire BTRS Holdings, a B2B accounts receivable automation and integrated payments company, in an all-cash transaction valuing Billtrust's equity at $1.7 billion.
  • FingerMotion, Inc. (NASDAQ: FNGR) gained 58.9% to close at $1.70.
  • Biogen Inc. (NASDAQ: NASDAQ:BIIB) shares rose 39.9% to close at $276.61. Biogen and Eisai Co. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.
  • bioAffinity Technologies, Inc. (NASDAQ: BIAF) rose 37.7% to close at $2.92 after the company announced it received an additional $7.7 million from the exercise of warrants.
  • Missfresh Limited (NASDAQ: MF) gained 34.9% to close at $0.1160.
  • KLX Energy Services Holdings, Inc. (NASDAQ: KLXE) climbed 30.3% to close at $6.97. KLX Energy Services raised Q3 sequential revenue growth from 9%-13% to 16%-18% and adjusted EBITDA from 10%-12% to 14%-16%.
  • Top Ships Inc. (NASDAQ: TOPS) gained 29.5% to close at $3.03 after the company announced 1H FY22 revenue of $38.8 million, which is up 53% year over year.
  • Quanterix Corporation (NASDAQ: QTRX) gained 29.2% to close at $10.41.
  • HeartBeam, Inc. (NASDAQ: BEAT) jumped 27.9% to close at $3.44. HeartBeam was granted patent for signal transformation from vector electrocardiogram to 12-lead electrocardiogram.
  • Iveda Solutions, Inc. (NASDAQ: IVDA) rose 24.2% to close at $0.67.
  • Blue Apron Holdings, Inc. (NYSE: APRN) jumped 24% to settle at $6.21 on above-average volume amid retail investor interest.
  • AC Immune SA (NASDAQ: ACIU) gained 23.8% to close at $3.12. Shares of companies with Alzheimer's programs traded higher after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
  • MorphoSys AG (NASDAQ: MOR) rose 23.4% to settle at $5.49.
  • ProMIS Neurosciences, Inc. (NASDAQ: PMN) rose 23.2% to close at $6.15.
  • Owlet, Inc. (NYSE: OWLT) gained 22.9% to close at $1.29. Owlet, last month, posted a Q2 loss of $0.16 per share.
  • Senmiao Technology Limited (NASDAQ: AIHS) rose 22.2% to close at $1.02.
  • Neuronetics, Inc. (NASDAQ: STIM) climbed 21.9% to close at $2.90.
  • Nano-X Imaging Ltd. (NASDAQ: NNOX) climbed 21.2% to close at $12.33. Nano X Imaging, last month, posted a Q2 loss of $0.16 per share.
  • Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 21% to settle at $1.44. Spruce Biosciences, last month, posted a Q2 loss of $0.51 per share.
  • Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) gained 20.1% to close at $3.47.
  • Aspen Group, Inc. (NASDAQ: ASPU) gained 19.7% to close at $0.3947. Aspen Group Director Douglas Kass acquired a total of 61,500 shares at an average price of $0.42.
  • Aura Biosciences, Inc. (NASDAQ: AURA) gained 19.2% to settle at $18.35. Aura Biosciences said first patient was dosed in Phase 1 study evaluating belzupacap sarotalocan (AU-011) for the treatment of non-muscle invasive bladder cancer.
  • Heliogen, Inc. (NYSE: HLGN) climbed 19.2% to settle at $2.05.
  • Denali Therapeutics Inc. (NASDAQ: DNLI) gained 17.7% to close at $32.12.
  • Workiva Inc. (NYSE: WK) jumped 17.6% to close at $76.15. Workiva is said to draw Thoma Bravo, TPG interest, Bloomberg reported.
  • Sonder Holdings Inc. (NASDAQ: SOND) gained 16.8% to close at $1.80.
  • Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) surged 16.2% to settle at $2.22.
  • RadNet, Inc. (NASDAQ: RDNT) gained 16.1% to close at $21.13.
  • Equinox Gold Corp. (NYSE: EQX) jumped 16% to settle at $3.56.
  • Atara Biotherapeutics, Inc. (NASDAQ: ATRA) gained 15.3% to close at $3.84. Atara Biotherapeutics will receive additional near-term milestone payment under updated tabelecleucel commercialization agreement with Pierre Fabre.
  • Coeur Mining, Inc. (NYSE: CDE) jumped 15.2% to close at $3.26.
  • New Gold Inc. (NYSE: NYSE:NGD) gained 13.5% to close at $0.84.
  • Peabody Energy Corporation (NYSE: BTU) gained 11.6% to close at $24.85.
  • Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4% to close at $5.85.
  • Invitae Corporation (NYSE: NVTA) gained 11% to close at $2.62.
  • Yamana Gold Inc. (NYSE: AUY) gained 10% to close at $4.41.
  • Lilly and Company (NYSE: LLY) rose 7.5% to close at $334.38. Shares of companies with potential Alzheimer's treatments traded higher in sympathy with Biogen.
  • Janux Therapeutics, Inc. (NASDAQ: JANX) gained 6.3% to close at $13.60.

Losers

  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) dipped 66.2% to close at $0.2570 after the company announced it received a notice that its partner SFJ Pharmaceuticals Group elected to transfer bentracimab rights to SFJ as PhaseBio failed to remedy its Going Concern Condition.
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) shares fell 47.1% to close at $3.24 after the company priced a 7.05 million share offering of common shares and warrants at $4.25 per share plus warrants.
  • Nano Labs Ltd (NASDAQ: NA) dropped 34% to close at $2.10 after the company priced a roughly 2.08 million ADS public offering at $2.40 per ADS.
  • iBio, Inc. (NYSE: IBIO) shares fell 32.3% to close at $0.2140 after the company reported FY22 preliminary sales results and announced a 1-for-25 reverse stock split.
  • Sonendo, Inc. (NASDAQ: SONX) fell 28.7% to close at $1.19.
  • NuZee, Inc. (NASDAQ: NUZE) dipped 28.2% to close at $0.3127.
  • SAI.TECH Global Corporation (NASDAQ: SAI) dropped 27% to close at $3.06.
  • SAI.TECH announced launch of new liquid cooling bitcoin mining infrastructure products.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) declined 24.4% to close at $3.03.
  • Allego N.V. (NYSE: ALLG) dipped 23.1% to close at $4.52.
  • Pineapple Energy Inc. (NASDAQ: PEGY) fell 22.9% to close at $1.11. Pineapple Energy recently named Eric Ingvaldson as new Chief Financial Officer.
  • iPower Inc. (NASDAQ: IPW) dropped 22% to close at $0.80 after the company released its financial results for its fiscal fourth quarter and full year ended June 30, 2022.
  • Loyalty Ventures Inc. (NASDAQ: LYLT) dropped 20% to close at $1.40.
  • Oriental Culture Holding LTD (NASDAQ: OCG) fell 19.2% to close at $0.9048.
  • Gamida Cell Ltd. (NASDAQ: GMDA) fell 17.4% to close at $1.62 after the company priced 12.9 million share public offering of common stock at $1.55 per share.
  • A2Z Smart Technologies Corp. (NASDAQ: AZ) fell 15.7% to close at $1.83.
  • Vitru Limited (NASDAQ: VTRU) dropped 15.4% to close at $18.00.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) fell 15.2% to close at $28.49.
  • Presto Automation, Inc (NASDAQ: PRST) fell 13.4% to close at $2.33. The company recently completed its previously announced business combination with Ventoux CCM Acquisition.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) fell 11.2% to close at $6.45. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
  • LiveWire Group Inc (NYSE: LVWR) fell 10.9% to close at $7.35.
  • Novonix Limited (NYSE: NVX) fell 10.7% to close at $4.75.
  • XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 9.6% to close at $1.22.
  • Algoma Steel Group Inc. (NASDAQ: ASTL) fell 9.6% to close at $6.71. Algoma Steel said it sees Q2 adjusted EBITDA of $75 million to $80 million.
  • Sandstorm Gold Ltd. (NYSE: SAND) fell 9.3% to close at $5.05 after the company announced an $80 million bought deal financing.
  • Amprius Technologies, Inc. (NYSE: AMPX) dropped 9% to close at $10.84.
  • V.F. Corporation (NYSE: VFC) fell 6.9% to settle at $32.66 after the company cut its FY23 EPS guidance below analyst estimates.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email